How Will the Market React to Align Technology, Inc. (ALGN) Stock Getting a Bearish Rating

Overall market sentiment has been down on Align Technology, Inc. (ALGN) stock lately. ALGN receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Align Technology, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ALGN!

See Full ALGN Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ALGN Stock Today?

Align Technology, Inc. (ALGN) stock is trading at $222.10 as of 2:34 PM on Friday, Dec 1, a rise of $8.30, or 3.88% from the previous closing price of $213.80. The stock has traded between $212.41 and $225.19 so far today. Volume today is light. So far 685,620 shares have traded compared to average volume of 1,459,947 shares. To see InvestorsObserver's Sentiment Score for Align Technology, Inc. click here.

More About Align Technology, Inc.

Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants). Click Here to get the full Stock Report for Align Technology, Inc. stock.